[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB9319500D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB9319500D0
GB9319500D0 GB939319500A GB9319500A GB9319500D0 GB 9319500 D0 GB9319500 D0 GB 9319500D0 GB 939319500 A GB939319500 A GB 939319500A GB 9319500 A GB9319500 A GB 9319500A GB 9319500 D0 GB9319500 D0 GB 9319500D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB939319500A
Other versions
GB2271059B (en
GB2271059A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB9319500D0 publication Critical patent/GB9319500D0/en
Publication of GB2271059A publication Critical patent/GB2271059A/en
Application granted granted Critical
Publication of GB2271059B publication Critical patent/GB2271059B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9319500A 1992-09-23 1993-09-21 Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives. Expired - Fee Related GB2271059B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN92112022 1992-09-23
CN93106028A CN1042895C (en) 1992-09-23 1993-05-27 Medicines composition and its method for treating drop syndrome and de-addiction of drugaddict

Publications (3)

Publication Number Publication Date
GB9319500D0 true GB9319500D0 (en) 1993-11-03
GB2271059A GB2271059A (en) 1994-04-06
GB2271059B GB2271059B (en) 1996-09-18

Family

ID=25742810

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9319500A Expired - Fee Related GB2271059B (en) 1992-09-23 1993-09-21 Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives.

Country Status (2)

Country Link
CN (1) CN1042895C (en)
GB (1) GB2271059B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547956A (en) * 1991-07-18 1996-08-20 Yueqian Qu Pharmaceutical composition and the method for treating drug addicts' withdrawal syndromes and detoxifying addicts by the same
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
WO1999011250A2 (en) 1997-09-04 1999-03-11 Novoneuron, Inc. Noribogaine in the treatment of pain and drug addiction
CN1116040C (en) * 2000-01-19 2003-07-30 曲日谦 Medicinal composition and its antalgic purpose
CN100443083C (en) * 2005-03-25 2008-12-17 成都高新区智爽天然产物科技有限责任公司 Use of aconine in medicine manufacture
CN1875968B (en) * 2005-06-08 2010-05-05 郑萍 Application of anisodamine in preparation of smoking-stopping medicament
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
UA111065C2 (en) 2010-07-23 2016-03-25 Демеркс, Інк. Noribogaine compositions
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
CN102796096B (en) * 2011-05-27 2016-09-14 中国科学院上海药物研究所 Hexahydro dibenzo [a, g] quinolizine compounds, its preparation method, pharmaceutical composition and application thereof
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
JP2015500833A (en) 2011-12-09 2015-01-08 デメレックス， インコーポレイテッド Nolibogaine phosphate
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
CA2858820C (en) 2012-01-25 2021-08-17 Demerx, Inc. Synthetic voacangine
JP2016508979A (en) 2012-12-20 2016-03-24 デメレックス， インコーポレイテッド Substituted norbogaine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
US9345711B2 (en) 2014-02-18 2016-05-24 Demerx, Inc. Methods for acute and long-term treatment of drug addiction
CA2989550C (en) 2014-06-18 2023-08-08 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
CN110478350A (en) * 2018-07-27 2019-11-22 上海品姗医药咨询有限公司 The application of bulleyaconitine A and its derivative in the preparation inhibition addicted drug of drug

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55167226A (en) * 1979-06-14 1980-12-26 Osaka Chem Lab Analgesic and antinflammatory agent, and its preparation
CH661208A5 (en) * 1983-09-01 1987-07-15 Inst Khim Rastitelnykh Vesches MEDICINAL PRODUCT WITH ANTI-ARRHYTHMIC EFFECT.

Also Published As

Publication number Publication date
GB2271059B (en) 1996-09-18
CN1087516A (en) 1994-06-08
GB2271059A (en) 1994-04-06
CN1042895C (en) 1999-04-14

Similar Documents

Publication Publication Date Title
GB9224855D0 (en) Pharmaceutical compositions
GB9209078D0 (en) Pharmaceutical compositions
GB9319500D0 (en) Pharmaceutical composition
HUT66864A (en) Pharmaceutical compositions
GB2272375B (en) Pharmaceutical composition
EP0587047A3 (en) Gestagenes containing pharmaceutical composition
GB9209874D0 (en) Pharmaceutical compositions
CA2100836A1 (en) Pharmaceutical Composition
GB9221707D0 (en) Pharmaceutical composition
ZA94155B (en) Pharmaceutical composition
ZA935078B (en) Pharmaceutical composition
GB9226377D0 (en) Pharmaceutical compositions
ZA935931B (en) Pharmaceutical composition
ZA924061B (en) Pharmaceutical composition
GB9211276D0 (en) Pharmaceutical compositions
ZA931984B (en) Pharmaceutical composition
GB9211903D0 (en) Pharmaceutical composition
GB9204472D0 (en) Pharmaceutical composition
GB9225159D0 (en) Pharmaceutical composition
GB9203897D0 (en) Pharmaceutical composition
GB9221003D0 (en) Pharmaceutical composition
GB9203248D0 (en) Pharmaceutical composition
GB9216600D0 (en) Pharmaceutical composition
GB9215976D0 (en) Pharmaceutical composition
GB9216596D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20040921